Innate Pharma SA
1.7160
17-9月-25 01:41:37
15 分の遅延
株式
-0.0960
-5.30%
本日の幅
1.6440 - 1.7240
ISIN
FR0010331421
ソース
Cboe
-
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
20 4 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
18 4 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma reports Full Year 2020 financial results and business update
17 3 2021 23:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
15 3 2021 23:00:00 提供 Nasdaq GlobeNewswire
-
Number of shares and voting rights of Innate Pharma as of February 1, 2021
23 2 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
16 2 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma advances lacutamab clinical development program
08 2 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
02 2 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
Innate's first NK cell engager selected by Sanofi as drug candidate for development
04 1 2021 22:00:00 提供 Nasdaq GlobeNewswire
-
Innate Pharma to participate in upcoming investor conferences
03 1 2021 22:00:00 提供 Nasdaq GlobeNewswire